Assessing the revised clinical institute withdrawal for alcohol scale (CIWA-Ar) use at Stikland Hospital

Simple item page
dc.contributor.advisorWeich, Lizeen_ZA
dc.contributor.authorMuddapah, Creeshen Pillayen_ZA
dc.contributor.otherStellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Psychiatry.en_ZA
dc.date.accessioned2022-11-21T14:37:44Z
dc.date.accessioned2023-01-16T12:50:50Z
dc.date.available2022-11-21T14:37:44Z
dc.date.available2023-01-16T12:50:50Z
dc.date.issued2022-12
dc.descriptionThesis (MMed)--Stellenbosch University, 2022.en_ZA
dc.description.abstractENGLISH SUMMARY: Background: Alcohol use disorder is a major public health concern in South Africa. Abrupt cessation or reduction of alcohol intake in the chronic user can result in withdrawal symptoms. Benzodiazepines are recognised as the treatment of choice but need to be used cautiously in patients with a lifetime history of substance abuse given their highly addictive potential. Symptom-triggered prescription of benzodiazepines during alcohol withdrawal using the Revised Clinical Institute Withdrawal for Alcohol Scale (CIWA-Ar) has been associated with improved safety and reduced benzodiazepines use. Aim: To investigate if implementation of the CIWA-Ar during alcohol detoxification impacted the amount of benzodiazepines used and withdrawal-related outcomes in a specialized alcohol rehabilitation unit at Stikland Psychiatric Hospital in the Western Cape, South Africa. Methods: We conducted a retrospective cohort study of 135 admissions over a six month period before (2015) and after (2017) implementation of the CIWA-Ar. Results: We noted no differences in sociodemographic and alcohol-associated variables at admission between the two groups and there were no recorded complications in either group. The 2017 group had a lower percentage of patients that required benzodiazepines (33.8% vs 51.4%, p=0.04) and a lower median total amount of benzodiazepines used during alcohol withdrawal (0mg vs 5mg, p=0.01). Conclusions: The findings indicate that using the CIWA-Ar rating scale to determine benzodiazepines requirements in the specialised alcohol rehabilitation unit was a safe and effective alternative to pro re nata benzodiazepines prescribing in the South African setting and decreased the amount of benzodiazepines used during alcohol withdrawal.en_ZA
dc.description.abstractAFRIKAANSE OPSOMMING: Geen opsomming beskikbaar.af_ZA
dc.description.versionMasters
dc.format.extent29 pages : includes annexures
dc.identifier.urihttp://hdl.handle.net/10019.1/126115
dc.language.isoen_ZAen_ZA
dc.publisherStellenbosch : Stellenbosch University
dc.rights.holderStellenbosch University
dc.subjectAlcohol withdrawal syndrome -- Cape Town (South Africa)en_ZA
dc.subjectSubstance abuse -- Treatment -- Cape Town (South Africa)en_ZA
dc.subjectAlcoholism -- Treatment -- Cape Town (South Africa)en_ZA
dc.subjectUCTD
dc.titleAssessing the revised clinical institute withdrawal for alcohol scale (CIWA-Ar) use at Stikland Hospitalen_ZA
dc.typeThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
muddapah_revised_2022.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Masters Degrees (Psychiatry)